Insulin human
ArticlesRefrigerated StorageLactation Safety Information · Published , updatedArticles
Safety in Lactation: Insulins
Exogenous insulin is excreted into breast milk, including that from insulin analogues. Insulin in breast milk is thought to be necessary for intestinal maturation of… Insulin aspart Insulin detemir Insulin glargine Insulin glulisine Insulin human Insulin isophane human Insulin lisproSoluble Insulin products: ambient stability during COVID-19
This page gives ambient stability information for soluble Insulin products during COVID-19. Information here should be used in conjunction with our general advice. Insulin soluble… COVID-19 Medicines Optimisation: Information and resources Insulin human Insulin soluble human Stability outside the fridgeInsulin preparations: RMOC recommendations of safety considerations for formulary decision making
At its meeting on 18th April 2018 the Regional Medicines Optimisation Committee (RMOC) (Midlands and East) reviewed issues pertaining to safety considerations when adopting any… Care homes Community Health Services Diabetes Insulin aspart Insulin aspart biphasic Insulin degludec Insulin degludec + Liraglutide Insulin detemir Insulin glargine Insulin glulisine Insulin human Insulin isophane biphasic human Insulin isophane biphasic porcine Insulin isophane bovine Insulin isophane human Insulin isophane porcine Insulin lispro Insulin lispro biphasic Insulin mixed bovine Insulin protamine zinc bovine Insulin soluble bovine Insulin soluble human Insulin soluble porcine Insulin zinc crystalline human Insulin zinc mixed human Primary Care RMOC recommendations and resources Transfer of care TrustsComparative table of insulin pumps 2018
Table compares features and functions of the ten insulin pumps currently available in the UK. Note: Cellnovo Limited has gone into administration and has ceased… Diabetes Insulin humanARCHIVED NPSA Alert – The adult patient’s passport to safer use of insulin 2011
This page forms part of a resource on medication related patient safety alerts issued by the National Patient Safety Agency (NPSA) between 2002 and 2012… Diabetes Insulin human Medicines SafetyARCHIVED NPSA Alert – Safer administration of insulin 2010
This page forms part of a resource on medication related patient safety alerts issued by the National Patient Safety Agency (NPSA) between 2002 and 2012… Diabetes Insulin human Medicines SafetyRefrigerated Storage
Insuman Basal, Insuman Rapid, Insuman Infusat, Insuman CombSanofi
In the event of an inadvertent temperature excursion the following data may be used:
For Insuman Infusat: The product (cartridges in-use in the pump) may be stored for a maximum of 2 weeks. The manufacturer states that once opened and attached to the pump, the storage conditions for the Insuman Infusat should comply with the ambient temperature of the pump.
The SPC and manufacturer do not specify the temperature range at which the Insuman Infusat should be stored at whilst within the pump, this will ultimately be a clinical decision made at the discretion of the treating healthcare professional.
For all other Insuman preparations: Once Insuman is taken out of the refrigerator for the first time, it can be kept for 28 days at temperatures of up to 25°C away from direct heat or direct light. Do not use Insuman if the storage temperature has exceeded 25°C.
Once a new pen or cartridge has been started, it is recommended to store the insulin pen at room temperature and not to put it back in the refrigerator, as the cold temperature may affect the mechanics of the pen and it may become difficult to use. The pen cap must be put back on the pen after each injection in order to protect from light.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
Pen products should be kept inside the box with the pen lids on to protect them from light. Do not freeze them or keep them near the freezer compartment of the refrigerator.